To investigate the influence of cholinergic pro jections from the basal forebrain on cerebral cortex me tabolism, we evaluated the cerebral metabolic rate of glucose (CMRG1u) after selective inhibition of cholinergic neurons in the rat basal forebrain using the pyruvate de hydrogenase complex inhibitor 3-bromopyruvic acid (BPA), and compared the results with those obtained after lesioning the basal forebrain with ibotenic acid, as well as with those from a sham-operated control group. CMRG l u was measured using positron emission tomogra phy (PET) with PSFj-2-fluoro-2-deoxY-D-glucose (FDG). Three days after surgery, CMRG,u and k3 (phosphoryla tion of FDG) were reduced similarly in the frontal cortex on the BPA-injected side and in the ibotenic acid-treated group, whereas Kl (transport rate of FDG from the Cholinergic projections from the basal forebrain to the cerebral cortex affect cortical metabolism, as demonstrated by the reduction in cerebral meta bolic rate of glucose (CMRGlu) observed after le sioning of the basal forebrain (London et aI., 1984; Orzi et aI., 1988; Kiyosawa et aI., 1989). In these studies, however, the cholinergic system could not be inhibited selectively, because the methods of le-
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sioning the basal forebrain, including electrolytic coagulation or application of neurotoxins, damaged neuronal structures other than those of the cholin ergic system (Pepeu et aI. , 1985) . In the present study, we evaluated frontal cortical CMRolu levels after selective inhibition of the cholinergic system in the basal forebrain of rats.
3-bromopyruvic acid (BPA) is an inhibitor of py ruvate dehydrogenase complex (PDHC) (Arendt et aI., 1990) , which has been reported to reduce the cholinergic neuronal activity of the cerebral cortex and cortical choline acetyltransferase activity. The procedure employing this inhibitor allows the selec tive cholinergic neuronal suppression of the cere bral cortex without concomitant basal forebrain de struction, and also excludes the possibility of the involvement of other ascending fiber systems such as monoaminergic or serotonergic projections (Dubois et aI., 1985; Lerer et aI., 1985) . We also examined changes in CMRolu levels with lesioning of the basal forebrain using ibotenic acid and com-pared the results with those of BPA administration to investigate the specificity and selectivity of the cholinergic suppressive effects of these procedures.
Serial CMRo1u measurement in the same rat was performed at 3 days and 3 weeks after operation using dynamic positron emission tomography (PET) with [ 18 p]-2-fluoro-2-deoxY-D-glucose (PDG). This method allows monitoring of· the time course of C M RGlu changes within the same animals as well as determination of glucose metabolic rate constants.
MATERIALS AND METHODS

Materials
Fifteen male Wistar rats weighing 250-350 g were ex amined. These rats were arbitrarily divided into the three groups: BPA-treated (n = 5), ibotenic acid-treated (n = 5), and sham-operated (n = 5) animals.
Surgical procedures. Rats were anesthetized with in traperitoneally injected sodium pentobarbital (20 mg/kg) and placed in a stereotaxic apparatus, the incisor bar of which was set 3. 3 mm below the interaural line. The ste reotaxic coordinates of the injection site were as follows: 1. 4 mm posterior to the bregma, 2. 8 mm right of the mid line, and 6. 9 mm below the surface of the brain, according to Paxinos and Watson's rat brain atlas (Paxinos et aI. , 1986) .
Either a 0.1 ILl volume of BPA solution consisting of 2 mM BP A and 0.2 mM thiamine pyrophosphate dissolved in 0.1 M phosphate buffered saline (PBS) (Arendt et aI. , 1990) or 0. 1 ILl of 2% ibotenic acid dissolved in 0. 1 M phosphate buffer (pH = 7.3) was injected with a Hamil ton micro syringe over a 5-min period at the right side of the nucleus basalis magnocellularis (NBM); the needle was removed over another 5-min period. Sham-operated rats were injected with 0.1 ILl of 0. 2 mM thiamine pyro phosphate dissolved in 0. 1 M PBS in the same manner as the other injected groups.
PETirnaging. PET examinations were performed in the same rats 3 days and 3 weeks after operation using a high-resolution PET scanner, designed for animal use, (SHR-2000, Hamamatsu Photonics K.K., Hamakita, Ja pan) equipped with four detector rings affording seven slice imaging. The spatial resolution at the center was 3 mm in-plane at full width at half maximum and 4. 8 mm axially. The averaged direct slice sensitivity was 2. 3 kcps/ ILCi/ml and the cross-slice sensitivity was 3. 8 kcps/ ILCi/ml. The total system sensitivity was 20. 7 kcps/ ILCi/ml including the scatter component (Watanabe et aI., 1992) .
Prior to imaging, rats were prepared by venous and arterial catheterization under sodium pentobarbital anes thesia and then placed in the prone position in the PET camera. The head of the rat was fixed horizontally with a molded plastic head-holder and positioned with the aid of a laser beam that allowed accurate repositioning for the second measurement 3 weeks later. A 20-min transmis sion scan using 68Ge/68Ga was performed for attenuation correction. Thirty min after anesthesia, 37 MBq (1 mCi) of FDG was injected intravenously and arterial blood col lected at the following times: 10, 30, 50, and 90 s, and 2, 3, 5, 10, 20, 30, 40, 50 , and 60 min. Serial dynamic PET data were also obtained simultaneously. Scans with a frame duration of 2 min were acquired successively; a total of 30 dynamic frames were obtained. Plasma glucose was determined twice, once prior to injection of FDG and once again upon cessation of scanning; the averaged value was used for CMRGlu calculation. During PET ex amination, systemic arterial blood pressure and arterial blood gases were monitored periodically and kept within physiological limits (blood pressure, 99. 5 ± 6.1 mmHg, Pac02: 39. 1 ± 1. 3 mmHg, Pa02: 93. 7 ± 1. 5 mmHg, and pH: 7. 41 ± 0. 02), and the rectal temperature maintained constant between 36 and 3rC with a heating pad.
Scanned data were reconstructed by Butterworth filter and Shepp-Logan filter as a 180 x 180 matrix image, with a pixel size of 1 x 1 mm.
PET data analysis. Each region of interest (ROI) were determined on the last 20 min of summed PET image data, and the same ROI were then transferred onto the dynamic scan data to obtain regional brain time activity curves. With reference to the magnetic resonance images (MRls) of each animal [1 mm slice thickness, 3 mm slice gap, obtained using a 1.5T imager (Signa Advantage, General Electric Co. Milwaukee, U. S. A. ) with the spin echo technique; TR = 3000 ms, TE = 100 ms] and the standard rat brain atlas, each ROI was placed symmetri cally and bilaterally in the frontal cortex and the basal forebrain ( Fig. 1 ). We measured cortical CMRG1u in the frontal cortex, because this region receives projections from vast numbers of cholinergic afferents from the basal forebrain (Saper, 1984) and because measurements in the cortex would not be confounded by direct damage pro duced by the injection needle. ROls in the basal forebrain were drawn over the affected NBM excluding the cere bral cortical region. Sizes of the ROls ranged from 20 to 36 mm2• Rate constants of glucose metabolism were determined by a nonlinear least squares algorithm fitted to the mea sured arterial and brain time activity curves (Fukuyama et aI. , 1989) , in which the vascular space was fixed as 4% (lngvar et aI., 1991) of total brain activity. CMRG1u was calculated using the obtained rate constants by the fol lowing formula:
where Cp is the plasma glucose level, LC denotes the lumped constant, kl is the rate constant for the FDG transport from the plasma to brain, k2 is the rate constant for the efflux from the brain to plasma compartment, and k3 is the rate constant for the phosphorylation of FDG. We used 0.58 as the value of LC (Lear and Ackerman, 1989) . Statistics. CMRG1u and the rate constants at 3 days postoperatively for the three groups were analyzed using a two-way analysis of variance (ANOV A) with respect to location, i.e. , injected or noninjected side of the frontal cortex or basal forebrain, and procedure, i. e., sham operated, ibotenic acid-treated, or BPA-treated groups. When the two-way ANOV A revealed cross reaction be tween two factors, a one-way ANOV A, including loca tions of ROls and types of operation, was performed. When no cross reaction was observed, one-way ANOV A was performed comparing the operation effects in either hemisphere separately. Multiple comparisons among
groups were performed with Scheffe's F-test. These pa rameters at 3 weeks postoperatively were also analyzed using the same test procedures. A p value of <0.05 was considered to be statistically significant.
Histology. The injection site was verified by adminis tering 0.05 f,ll of wheat germ agglutinin (WGA)-horse radish peroxidase (HRP) conjugate at the site with the same coordinates as the BPA or ibotenic acid injection. For histochemical demonstration of WGA-HRP, the sec tion was treated with tetramethylbenzidine (Mesulam, 1978) and then counterstained with 1% cresyl violet ( Fig.  2A) to visualize the center of the injection site. The brain was removed froIT. all rats after the 3-week PET exami nation to determine the injection site, as well as the spread of the necrotic area in the case of ibotenic acid treatment using cresyl violet staining (Figs. 2B and C). 
RESULTS
Three-days postoperatively (Table 1) Two-way ANOV A revealed significant alter ations in the CMRG1u for the experimental proce dures (p < 0.0001) and the locations of ROI (in jected side versus noninjected side) (p < 0.01) with cross-reactivity (p < 0.05). Thus, we also per formed a one-way ANOV A including the locations of ROI and the differences in procedures.
This one-way ANOV A revealed that the CMRG1u of the frontal cortex ipsilateral to the operated side was significantly lower than that in the sham operated group in both BPA and ibotenic acid treated groups. The injected and noninjected sides showed a marked difference in the ibotenic acidtreated, but not in the BPA-injected, group (Fig. 3) . The CMRGlu in the basal forebrain ipsilateral to the operated side was significantly reduced in the ibotenic acid-treated group compared to the sham operated and BPA-injected groups.
Two-way ANOV A indicated significant changes in k3 for the experimental procedures (p < 0.0001) and the locations of ROI (p < 0.01), but since there was no cross reaction between these two factors, we compared them separately. The rate constant k3 was significantly lower in the ipsilateral frontal cor tex in BPA-and ibotenic acid-treated rats than in the sham-operated animals. In the basal forebrain, k3 was decreased significantly in the ibotenic acid treated group compared to either the BPA-treated or sham-operated group. Two-way ANOV A indicated significant differ ences in kl and k2 for the experimental procedures (kl, p < 0.05; k2, p < 0.00 1). However, a post-hoc Scheffe's f-test could not detect any significant dif ferences among the kinds of operations.
Three-weeks postoperatively ( Table 2) Neither CMRo1u nor k3 was reduced in the fron tal cortex in any of the three groups (Fig. 3) . How ever, CMRo1u and k3 in the ipsilateral basal fore brain in the ibotenic acid-treated group remained low.
DISCUSSION
This experimental protocol is subject to several limitations, the first of which is the possibility of an anesthetic effect in the rats examined during PET scanning. The anesthesia level was, however, not so deep that the CMRo1u in this study was higher than previously reported values obtained under deep pentobarbital anesthesia (Otsuka, 1991) , but the influence of anesthesia cannot be excluded com pletely. Therefore, we compared experimental CMRo1u with that measured in a sham-operated group under similar anesthesia conditions. The sec ond limitation is that the sizes of the ROIs covered only a small portion of the rat brain; thus, data ob tained for areas less than twice the spatial resolu tion of the PET scanner may have been underesti mated (Baron and Miyazawa, 199 1) . A final limita tion is that, because we compared two different scanning data sets, we paid careful attention when positioning the head in the second scan-to fix it in the same position as in the first scan using the head holder; nevertheless, there might have been a small positioning error. Therefore, the present PET data were subject to the effects of anesthesia, partial vol ume effect, and positioning error, and these factors might have caused slight deviation of the observed data from actual values. However, there was no marked difference from the reported value for any of the metabolic rate constants obtained under the control conditions (Redies et al., 1987; Ingvar et aI., 1991) . Therefore, the present experimental proce dure seems to be valid.
We found that inhibition of the cholinergic sys tem in the basal forebrain reduced cortical CMRo1u to a degree comparable to that obtained by lesioning the basal forebrain by ibotenic acid administration. Our findings indicate that the cholinergic system in the basal forebrain affects cortical neuronal activity and metabolism. No reduction was apparent in kl, but k3 was significantly decreased, which suggests that the observed reduction in cortical glucose me tabolism was due to diminished glucose phosphorylation and that the glucose transport rate was not significantly affected by cholinergic denervation.
In the ibotenic acid-injected group, the CMRo1u in the ipsilateral basal forebrain was decreased. This reduction reflected the damage of both cholin ergic and noncholinergic neurons in the basal fore brain as a result of the neurotoxicity of ibotenic acid. The reduced CMRo1u in the cerebral cortex after ibotenic acid lesioning would include the ob served damage to these two types of neurons orig inating from the basal forebrain, and, therefore, it cannot necessarily be concluded from such experi ments that only cholinergic input from the basal forebrain affects cortical glucose metabolism. We applied selective inhibition, however, of the cortical cholinergic system with BPA. BPA irreversibly in activates PDHC, which has a regulatory function in carbohydrate and acetylcholine metabolism in brain tissue (Maldonado et aI., 1972; Lowe and Perham, 1984) and catalyzes the flux-generating step of the tricarboxylic acid cycle. Since < 1 % of pyruvate comprises the substrate for acetylcholine synthesis (Tucek and Cheng, 1974; Gibson and Blass, 1983) , acetylcholine synthesis may be more affected by PDHC inhibition than is carbohydrate metabolism. Our study disclosed no significant reduction in CMRGlu in the BPA-injected basal forebrain, indi cating that BPA administration did not substantially alter glucose metabolism via its inhibitory action on PDHC. Thus, we can exclude the possibility that the inhibited PDHC transported to the cortex from the basal forebrain was related to the observed CMRGlu reduction in the cortex.
The dose of BP A used in the present study was sufficient to inhibit PDHC activity by �90% at max imum in vitro and �40-80% in vivo (Arendt et aI., 1990) . The degree of CMRGlu reduction in the BPA treated group was slightly less marked than that in the ibotenic acid-lesioned group. Although the dif ference was not statistically significant, cortical glu cose metabolism was not completely suppressed by BPA, in contrast to the effect of ibotenic acid, and a proportion of PDHC was speculated to function in acetylcholine production in the cortex. The reduc tion of cortical CMRo1u in the BPA-treated group was not significantly different interhemispherically, in contrast to the significant difference observed be tween hemispheres in ibotenic acid-treated rats. The reason for this difference is unclear at present, but we speculate that the injected BPA may have spread and reached to contralateral side of the basal forebrain, resulting in equivalent suppression of PDHC in the cholinergic neurons of the contralat eral basal forebrain. Thus, when localized and com plete unilateral cholinergic suppression is required, ibotenic acid should be injected. On the other hand, diffuse but specific suppression of cholinergic sys tems in the cerebral cortex could be expected when BPA is injected.
The cholinergic system in the basal forebrain is related to vasodilatation and excitation of cortical neurons Dauphin et al., 1994) . Both the increase in cerebral blood flow (CBF) reported after basal forebrain stimulation (Biesold et al., 1989; Lacombe et al., 1989; Adachi et al., 1990; Linville and Arneric, 199 1; ) and the decrease in CBF described after lesioning of the basal forebrain (Gomi et al. , 199 1) support the con cept that the activity of the basal forebrain cholin ergic system is related to cortical vasodilatation. It was also reported that CBF does not change after lesioning of the basal forebrain (Scremin et al., 199 1; Namba et al., 199 1) . One biochemical study has suggested that the perimicrovascular cholin ergic terminals in the cerebral cortex do not origi nate from the basal forebrain (Galea et al., 199 1) . It is reasonable to speculate that the vasodilative ac tion of the cholinergic projections originated from the basal forebrain may be mediated through cholin ergic neuronal activation (Lamour et al. , 1982a) . The present results indicated that there were no marked alterations in the value of kl in any exper imental group. The constant kl represents glucose influx from blood vessels into the brain parenchyma and is the product of CBF and the glucose extrac tion fraction by the brain (Crane et al., 1983) . Thus, glucose transport from blood vessels into the brain was not influenced by cholinergic input suppres sion. The absence of marked deviations in kl and in the calculated distribution volume, Vd, of FDG (BPA: Vd = 0.409 ± 0.049; ibotenic acid: Vd = 0.349 ± 0.064; sham-operation: Vd = 0.377 ± 0.072) suggests the possibility that basal forebrain cholin ergic projections may not directly regulate cerebral cortical vessel reactivities.
In a previous study in baboons (Kiyosawa et al., 1989) , a tendency toward reduction in rate con stants kl and k3 was observed, but neither of these decreases was statistically significant. Our results indicate a reduced value of k3 on the injected side of the frontal cortex in both the BPA-and ibotenic acid-treated groups. Methodological differences, in cluding experimental lesioning technique, tomo graphic sensitivity, size of ROI, rate constant cal culation algorithm, and interspecies biological met abolic differences might have contributed to these differences in results for k3. Of course, inhibition of the cholinergic system in the basal forebrain would not lead directly to a reduction in k3. In vitro, ace tylcholine can regulate neuronal activities through J Cereb Blood Flow Metab, Vol. 16, No. 1, 1996 intracellular signaling processes such as those me diated by adenylate cyclase, phosphoinositide, or phospholipase C (Brown and Brown, 1984; Ash kenazi et al., 1987; Dauphin et al., 1994) . It has been shown pharmacologically that acetylcholine effec tively excites cortical neurons (Dam et al., 1982; Sato et al., 1987) . Thus, neuronal control by acetyl choline via these mechanisms presumably in creased the neuronal activity and energy demands of neurons, resulting in increased glucose consump tion, which was reflected as the increase in both CMR G lu and hexokinase activity, i. e., k3.
The initially reduced frontal cortex CMRG1u re covered 3 weeks after operation in both the BPA and ibotenic acid-treated groups. In a study of le sioning by ibotenic acid injection, basal forebrain neurons were considered to be necrosed, but recov ery of cortical neuronal activity was observed after 3 weeks (London et al., 1984) . The compensatory sprouting of cortical intrinsic cholinergic neurons (Lamour et al., 1982b; Sconcrant et al., 1992 ; Cos sette et al., 1993) may be responsible for the recov ery. Our results corroborate this possibility, as 3 weeks after operation there was still a low CMRalu in the basal forebrain, in which populations of cholinergic neurons would have remained damaged. Recovery after BPA treatment has been speculated to be due to gradual replacement of PDHC inhibited by BP A via intact enzyme transport from basal forebrain cholinergic neurons, thus clearing the in hibition from the cortical area (Weiss, 1969) . There fore, neither of these two experimental procedures mimics the state of permanent suppression of cor tical cholinergic neurons as seen in Alzheimer's dis ease, which is typified by defective cholinergic neu ronal activities in the basal forebrain (Whitehouse et al., 1982) as well as in the cortical intrinsic cholin ergic neurons due to pathological processes.
Our findings indicate that the cholinergic projection system from the basal forebrain plays an important role in regulating cerebral cortical metabolism through stimulating cortical neuronal activities.
